Guardant Multi-Cancer Detection

One 40 ml blood draw by Guardant Health screening for early DNA signals from 10 major cancers: bladder, breast, colorectal, esophageal, stomach, pancreatic, lung, liver, ovarian and prostate. 99% specificity (1% false positive rate), 74% sensitivity across the 6 most aggressive cancers, and 93% accuracy in predicting the cancer's origin when a signal is detected. Includes doctor consultation and report review at PROTOCOL.